Tag: Biliary Cholangitis
Zydus Cadila’s Saroglitazar granted ‘Orphan Drug Designation’ by USFDA
Saroglitazar Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gamma dual agonist used in the treatment of patients with Primary Biliary Cholangitis (PBC)........................